ImmuCell Corp. (Nasdaq: ICCC), a Portland-based biotech company that makes health products for cattle, on Monday reported financial results that showed a 46% sales increase for the first quarter of 2022, compared with the same period in 2021.
Last quarter’s total hit a record high for the company, reaching $6 million, and continuing a trend that included a 45% sales increase for Q4 2021. Read more
FORT KENT, Maine — Fort Kent middle schoolers are the state’s first students to learn at the newly unveiled Maine Mobile Biolab, a 50-foot,...
Anew medical lab training facility on the campus of University of Maine Augusta is nearly six times larger than an off-campus space...
The University of New England has received a grant from the Maine Department of Inland Fisheries and Wildlife to study one...